ABUS

4.0201.23%
RA

Robert Alan Beardsley

Independent Director

Dr. Robert A. Beardsley, also known as Al, Ph.D. MBA. is Independent Director of Arbutus Biopharma Corporation from February 25, 2025. Dr. Beardsley was the Co-Founder of Galera Therapeutics, Inc. until June 2, 2024 and served as its Chief Operating Officer since 2014 until June 2, 2024. He serves as the President and Chief Executive Officer of Cirius Therapeutics, Inc. Dr. Beardsley served as the Chief Business Officer of Confluence Life Sciences, Inc. and Confluence Discovery Technologies, Inc. He serves as the Executive Chairman, Secretary and Director of Epigenetx, LLC. He serves as Managing Member of SImile Investors LLC. He serves as Equity Analyst at Vector Securities International, LLC. He has experience growing life science companies, in private equity fundraising, partnering and clinical development of innovative pharmaceutical agents. He joined Kereos, Inc. in 2002 and served as its President and Chief Executive Officer since January 2003 until 2009. He was a co-founder of SImile Investors, LLC. He served as Acting Chief Executive Officer of MetaPhore Pharmaceuticals, Inc. where he played key roles in two successful private equity fundraising rounds. He also has held a number of positions in biotechnology and life science related firms, including bioStrategies Group. He served as the Chief Executive Officer of Metabolic Solutions Development Company since August 2009 to 2010. Dr. Beardsley was the Chief Executive Officer at Galera Therapeutics, LLC from 2010 to 2012. He served as the Executive Chairman of Galera Therapeutics Inc. from 2012 to 2017 and served as its Director. He has also served in various management roles at Confluence Life Sciences, bioStrategies Group, Enzyme Organics and Mobil Oil. He served as a Business Advisor and Director of Euclises Pharmaceuticals, Inc. He serves as Director of BioSeek Inc. and PharmaMonde. Dr. Beardsley served as a Director of CollaGenex Pharmaceuticals, Inc. from December 7, 2004 to April 10, 2008. He served as a Director of KemPharm, Inc. since 2007 and Kereos Inc. since January 2003. He served as a Director of Metaphore Pharmaceuticals Inc. Dr. Beardsley holds a Ph.D. in Biochemical Engineering and a B.S. in Chemical Engineering from the University of Iowa, along with an M.B.A. in Finance from the University of Chicago.

Positions